372 related articles for article (PubMed ID: 37492969)
1. ADT-OH synergistically enhanced the antitumor activity of celecoxib in human colorectal cancer cells.
Xu H; Li P; Ma H; Tan Y; Wang X; Cai F; Xu J; Sun H; Zhuang H; Hua ZC
Cancer Med; 2023 Aug; 12(16):17193-17211. PubMed ID: 37492969
[TBL] [Abstract][Full Text] [Related]
2. ADT-OH, a hydrogen sulfide-releasing donor, induces apoptosis and inhibits the development of melanoma in vivo by upregulating FADD.
Cai F; Xu H; Cao N; Zhang X; Liu J; Lu Y; Chen J; Yang Y; Cheng J; Hua ZC; Zhuang H
Cell Death Dis; 2020 Jan; 11(1):33. PubMed ID: 31949127
[TBL] [Abstract][Full Text] [Related]
3. Piperine and Celecoxib synergistically inhibit colon cancer cell proliferation via modulating Wnt/β-catenin signaling pathway.
Srivastava S; Dewangan J; Mishra S; Divakar A; Chaturvedi S; Wahajuddin M; Kumar S; Rath SK
Phytomedicine; 2021 Apr; 84():153484. PubMed ID: 33667839
[TBL] [Abstract][Full Text] [Related]
4. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells.
Xiao H; Zhang Q; Lin Y; Reddy BS; Yang CS
Int J Cancer; 2008 May; 122(9):2115-24. PubMed ID: 18172863
[TBL] [Abstract][Full Text] [Related]
5. Thymidine Kinase 1 Mediates the Synergistic Antitumor Activity of Ubenimex and Celecoxib via Regulation of Cell Cycle in Colorectal Cancer.
Wang A; Shang Y; Ni J; Wang W; Wang C; Li G; Chen SZ
J Pharmacol Exp Ther; 2022 Aug; 382(2):188-198. PubMed ID: 35868865
[TBL] [Abstract][Full Text] [Related]
6. AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells.
Venkatesan P; Bhutia SK; Singh AK; Das SK; Dash R; Chaudhury K; Sarkar D; Fisher PB; Mandal M
Life Sci; 2012 Oct; 91(15-16):789-99. PubMed ID: 22922496
[TBL] [Abstract][Full Text] [Related]
7. COX-2-independent induction of apoptosis by celecoxib and polyamine naphthalimide conjugate mediated by polyamine depression in colorectal cancer cell lines.
Xie SQ; Zhang YH; Li Q; Wang JH; Li JH; Zhao J; Wang CJ
Int J Colorectal Dis; 2012 Jul; 27(7):861-8. PubMed ID: 22159752
[TBL] [Abstract][Full Text] [Related]
8. A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells.
Toriyama S; Horinaka M; Yasuda S; Taniguchi T; Aono Y; Takamura T; Morioka Y; Miki T; Ukimura O; Sakai T
Mol Cancer Ther; 2016 Sep; 15(9):2066-75. PubMed ID: 27406983
[TBL] [Abstract][Full Text] [Related]
9. Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.
Zhang L; Tong Y; Zhang X; Pan M; Chen S
Drug Des Devel Ther; 2015; 9():5851-62. PubMed ID: 26586936
[TBL] [Abstract][Full Text] [Related]
10. ADT-OH inhibits malignant melanoma metastasis in mice via suppressing CSE/CBS and FAK/Paxillin signaling pathway.
Cai FF; Xu HR; Yu SH; Li P; Lu YY; Chen J; Bi ZQ; Sun HS; Cheng J; Zhuang HQ; Hua ZC
Acta Pharmacol Sin; 2022 Jul; 43(7):1829-1842. PubMed ID: 34795411
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo.
Rahman M; Selvarajan K; Hasan MR; Chan AP; Jin C; Kim J; Chan SK; Le ND; Kim YB; Tai IT
Neoplasia; 2012 Jul; 14(7):624-33. PubMed ID: 22904679
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of lovastatin and celecoxib on caveolin-1 and its down-stream signaling molecules: Implications for colon cancer prevention.
Guruswamy S; Rao CV
Int J Oncol; 2009 Nov; 35(5):1037-43. PubMed ID: 19787257
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma.
Xiong S; Huang W; Liu X; Chen Q; Ding Y; Huang H; Zhang R; Guo J
Cell Transplant; 2022; 31():9636897221077921. PubMed ID: 35176901
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.
Cianchi F; Cortesini C; Magnelli L; Fanti E; Papucci L; Schiavone N; Messerini L; Vannacci A; Capaccioli S; Perna F; Lulli M; Fabbroni V; Perigli G; Bechi P; Masini E
Mol Cancer Ther; 2006 Nov; 5(11):2716-26. PubMed ID: 17121918
[TBL] [Abstract][Full Text] [Related]
15. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
Swamy MV; Cooma I; Reddy BS; Rao CV
Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
[TBL] [Abstract][Full Text] [Related]
16. Metformin Synergistically Enhanced the Antitumor Activity of Celecoxib in Human Non-Small Cell Lung Cancer Cells.
Cao N; Lu Y; Liu J; Cai F; Xu H; Chen J; Zhang X; Hua ZC; Zhuang H
Front Pharmacol; 2020; 11():1094. PubMed ID: 32792943
[TBL] [Abstract][Full Text] [Related]
17. Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancer.
Zhang DQ; Guo Q; Zhu JH; Chen WC
World J Surg Oncol; 2013 Jan; 11():16. PubMed ID: 23347845
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib and bevacizumab synergistically inhibit non-small cell lung cancer by inducing apoptosis and modulating VEGF and MMP-9 expression.
Qadir A; Khalid Z; Kashan Theba F; Mujtaba Ali M; Asif M; Rizvi F
Pak J Pharm Sci; 2023 Mar; 36(2):501-506. PubMed ID: 37530158
[TBL] [Abstract][Full Text] [Related]
20. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
